Orane Life Sciences

Country/Region: India     State/Province: New Delhi

Company Introduction
Our Drug Intermediates goes through a top-notch quality analysis system supervised by skilled quality auditors who assess different products at different level. We have developed a state-of-the-art facility located in NEW DELHI, , India, laced with all the required amenities to keep the Drug Intermediates quality consistent and maintained. Buyers can reach us for acquiring first in class Drug Intermediates, as we are enlisted among best in class Manufacturers since 2004.Entire product line from Orane Life Sciences LLC are made available in different variations with quality commitments that has no match, making our Drug Intermediates and Drug Intermediates highly demanded in the international market. Owing to which our export ratio value has reached Above US$100 Million based on Australia,Canada,Switzerland,Germany,United Kingdom market share. Being a quality-conscious entity and a leading Exporter of Drug Intermediates, we make sure that all our products perfectly comply with the laid industry standards and boast supreme quality. This approach throughout our 16 Years of export history led us to acquire Approx 0.8 Million US Dollar of yearly output.Our professional enterprise was first launched with Above US$100 Million of initial investment under Agency.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2004, 2004

Legal Status: Agency

Ownership: LLC

Employees: Above 1000 People

Factory Size: 1, 000-3, 000 square meters

R&D Team Size: Fewer than 5

Certifications: ISO14001

Contact Information

Contact Person: Orane

Designation: Industrial designer

Department: Marketing Manager

Telephone: 91912024000000

Business Information

Main Markets: Canada (27%) Germany (26%) Switzerland (18%) Australia (13%) United Kingdom (11%)

Export Focus: Australia, Canada, Switzerland, Germany, United Kingdom

Contract Services: OEM Service Offered

Trade & Financial Information

Annual Revenue: Approx 0.8 Million US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 41% - 50%

Payment Terms: Bank wire (T/T)

Product Showcase
Drug Intermediates
Drug Intermediates

CL-Link > Health & Medicines in India Health & Medicines in New Delhi Health Care Supplement in India Health Care Supplement in New Delhi Drug Intermediates in India Drug Intermediates in New Delhi